Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Lifts Curtain On Homeopathics Regulatory Evaluation With Public Hearing

This article was originally published in The Tan Sheet

Executive Summary

FDA’s public hearing announcement comes a week after it alerted consumers to the prevalence of homeopathics with violative indications for treating asthma and could signal the start of the separate review of homeopathic regulations the agency said it would undertake when the OTC drug review began in 1972.

You may also be interested in...



FDA Urged To Change OTC Monograph System, But Not In Midstream

“Moving away from the monograph system when we are so close to the end” would “risk setting back the OTC drug review many years or even decades,” CHPA head Scott Melville says at an FDA public hearing. Other stakeholder s explain how the monograph system has failed industry and consumers.

Flu Therapy “Scammers” Prompt FDA, FTC Warnings

Recent FDA warning letters include one to Oasis Consumer Healthcare regarding marketing and labeling for Halo Oral Antiseptic Spray. The agency also teamed with FTC to warn three online health stores for making flu claims for supplement products.

Science-Based Evaluation Advocates Want Tighter Homeopathic Oversight

Public health concerns should prompt FDA to tighten its regulation of homeopathic drugs, a citizen petition filed by the nonprofit Center for Inquiry says.

Topics

UsernamePublicRestriction

Register

PS107577

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel